VentriPoint Diagnostics Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of VentriPoint Diagnostics Ltd. generated cash of -$3,803,894, which is more than the previous year. Cash used in financing activities reached the amount of -$102,355 last year. Net change in cash is therefore -$3,891,424.
Cash Flow
| 2014 | -1.26M | -31.01K | 1.04M |
|---|---|---|---|
| 2015 | -1.60M | 0 | 3.36M |
| 2016 | -2.19M | -13.32K | 436.00K |
| 2017 | -3.06M | -39.04K | 4.24M |
| 2018 | -3.04M | -27.37K | 1.83M |
| 2019 | -2.38M | -17.09K | 2.34M |
| 2020 | -1.10M | -3.76K | 1.62M |
| 2021 | -3.14M | -4.25K | 11.89M |
| 2022 | -4.13M | 0 | 87.64K |
| 2023 | -3.80M | 0 | -102.35K |
VPT.V Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.18M | 9.26M | 526.02K | 13.76K | 66.56K | 1.35M | 191.28K | 1.97M | 205.77K | 398.80K |
Operating activities | ||||||||||
Net income | -4.87M | -4.87M | -3.88M | -1.85M | -3.32M | -2.08M | -3.70M | -2.62M | -1.51M | -2.18M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 66.66K | 50.90K | 48.81K | 54.94K | 60.31K | 28.28K | 12.71K | 10.98K | 13.91K | 28.85K |
Stock-based compensation expense | 493.30K | 798.05K | 898.3K | 394.84K | 205.10K | 0 | 486.30K | 70.91K | 128.17K | 291.82K |
| Deferred income tax benefit | 493.30K | 798.05K | 898.3K | 394.84K | 205.10K | 0 | 486.30K | 70.91K | 128.17K | 291.82K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 88.67K | -176.68K | -32.15K | -97.68K | 12.56K | 19.58K | 29.11K | -64.71K | 29.01K | 75.39K |
Inventories | 0 | 176.68K | 32.15K | 30.82K | 38.16K | -18.40K | -38.61K | -11.96K | 75.85K | 104.31K |
Accounts payable | 285.33K | -86.76K | -396.04K | 145.59K | 336.37K | 143.94K | -369.74K | -3.43K | -1.41K | 47.09K |
Cash generated by operating activities | -3.80M | -4.13M | -3.14M | -1.10M | -2.38M | -3.04M | -3.06M | -2.19M | -1.60M | -1.26M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 4 | 0 | -4.25K | -3.76K | -17.09K | -27.37K | -39.04K | -13.98K | 0 | -31.01K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 661 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | -4.25K | -3.76K | -17.09K | -27.37K | -39.04K | -13.32K | 0 | -31.01K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 138.35K | 8.05M | 530.8K | 703.07K | 1.86M | 4.67M | 637K | 3.19M | 1.25M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -102.35K | -50.70K | -48.86K | -13.16K | 1.68M | 0 | -109K | -160K | 153.51K | -63.19K |
Cash used in financing activities | -102.35K | 87.64K | 11.89M | 1.62M | 2.34M | 1.83M | 4.24M | 436.00K | 3.36M | 1.04M |
Net Change In Cash | -3.89M | -4.08M | 8.74M | 512.26K | -52.80K | -1.29M | 1.16M | -1.78M | 1.77M | -226.67K |
Cash at end of period | 1.29M | 5.18M | 9.26M | 526.02K | 13.76K | 66.56K | 1.35M | 191.28K | 1.97M | 172.13K |